NEWSROOM

March 14, 2024

SHL Telemedicine receives buy rating with $11.00 price target

March 14, 2024

Ad-hoc announcement pursuant to Art. 53 LR

SHL announces change in CEO position

February 8, 2024

SHL announces Annual General Meeting Results

February 6, 2024

Ad-hoc announcement pursuant to Art. 53 LR

Update regarding upcoming Annual General Meeting – Change in theComposition of the Board of Directors

February 1, 2024

Imperial College London TELE-ACS clinical trial results, using SHLTelemedicine’s SmartHeart® technology, to be presented at ACC 24

December 28, 2023

AGM 2023 announcement

December 19, 2023

SHL Telemedicine and BARMER to Highlight Digital Patient Care at BMC Congress 2024

November 27, 2023

SHL Telemedicine Introduces SmartHeart® Direct-to-Consumer MembershipPlan in the US

November 6, 2023

SHL Telemedicine Establishes US Nationwide Cardiology Network for ECG Interpretations and Telehealth Visits